Development and validation of a ultraperformance liquid chromatography–tandem mass spectrometry method for quantifying free and total dabigatran in human plasma: An application for a bioequivalence study-Reference-Cited by-同舟云学术

Development and validation of a ultraperformance liquid chromatography–tandem mass spectrometry method for quantifying free and total dabigatran in human plasma: An application for a bioequivalence study

Published:2022-05-06 Issue:7 Volume:36 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Abd Allah Fathy Ibrahim¹²,Ali Almrasy Ahmed³,Abdelhmaid Ahmed²,Abd‐Elmegid Osama A.²,Alkashlan Akram²,El‐Attar Abdul‐Aziz M. M.³^ORCID

Affiliation:

1. Department of Pharmaceutics, Faculty of Pharmacy Al‐Azhar University Cairo Egypt

2. International Center for Bioavailability, Pharmaceutical, and Clinical Research Obour City Egypt

3. Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy Al‐Azhar University Cairo Egypt

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.5382

Reference49 articles.

1. Oral Anticoagulant Therapy

2. Validation of an LC–MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma

3. Development and Validation of a Stability-Indicating Liquid Chromatography Method for the Determination of Dabigatran Etexilate in Capsules

4. The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans

5. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the role of current mass spectrometry in pharmaceutical analysis?;Mass Spectrometry Reviews;2023-07-28